This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
MGC Diagnostics Corporation
MGC Diagnostics Corporation, a leading name in the cardiopulmonary diagnostics industry, is headquartered in the United States. Founded in 1977, the company has established itself as a pioneer in developing innovative solutions for respiratory and cardiovascular health. With a strong presence in North America and Europe, MGC Diagnostics focuses on advanced diagnostic systems and services that enhance patient care. The company’s core offerings include cardiopulmonary exercise testing, pulmonary function testing, and sleep diagnostics, distinguished by their precision and user-friendly design. MGC Diagnostics is recognised for its commitment to quality and innovation, positioning itself as a trusted partner in healthcare. Notable achievements include a robust portfolio of patented technologies that set industry standards, ensuring MGC Diagnostics remains at the forefront of the diagnostics market.
DitchCarbon Score
How does MGC Diagnostics Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MGC Diagnostics Corporation's score of 47 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MGC Diagnostics Corporation, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Niterra Co., Ltd., which influences its climate commitments and initiatives. While MGC Diagnostics Corporation has not established its own reduction targets, it inherits climate initiatives from Niterra Co., Ltd. at a cascade level of 2. This includes participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which are frameworks aimed at driving corporate climate action and transparency. However, specific targets or achievements related to emissions reductions have not been disclosed. As part of its commitment to sustainability, MGC Diagnostics Corporation aligns with the broader climate strategies of its parent company, Niterra Co., Ltd., although detailed metrics or specific reduction goals are not available at this time. The company’s climate commitments reflect an industry trend towards greater accountability and action on climate change, even in the absence of direct emissions reporting.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2003 | 2004 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 59,880,000 | 00,000,000 | - | - | - | - | - | - | - |
| Scope 2 | - | - | - | - | - | - | - | - | - |
| Scope 3 | - | - | - | - | - | - | - | 00,000,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MGC Diagnostics Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
